Exposure Chamber Trial With Cat Immunotherapy

NCT00987909 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Cat Allergy

Interventions

BIOLOGICAL: Specific allergen immunotherapy (placebo)
BIOLOGICAL: Specific allergen immunotherapy
BIOLOGICAL: Specific allergen immunotherapy
BIOLOGICAL: Specific allergen immunotherapy

Sponsor

ALK-Abelló A/S

Collaborators

[object Object]